Credit Suisse’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,280
| Closed | -$244K | – | 3906 |
|
|
2022
Q4 | $244K | Sell |
11,280
-136
| -1% | -$2.94K | ﹤0.01% | 3101 |
|
|
2022
Q3 | $221K | Buy |
11,416
+81
| +0.7% | +$1.57K | ﹤0.01% | 3192 |
|
|
2022
Q2 | $225K | Buy |
11,335
+489
| +5% | +$9.71K | ﹤0.01% | 3273 |
|
|
2022
Q1 | $324K | Buy |
10,846
+734
| +7% | +$21.9K | ﹤0.01% | 3172 |
|
|
2021
Q4 | $235K | Buy |
10,112
+833
| +9% | +$19.4K | ﹤0.01% | 3392 |
|
|
2021
Q3 | $290K | Buy |
9,279
+79
| +0.9% | +$2.47K | ﹤0.01% | 3265 |
|
|
2021
Q2 | $324K | Sell |
9,200
-2,828
| -24% | -$99.6K | ﹤0.01% | 3251 |
|
|
2021
Q1 | $424K | Sell |
12,028
-6,901
| -36% | -$243K | ﹤0.01% | 3035 |
|
|
2020
Q4 | $711K | Buy |
+18,929
| New | +$711K | ﹤0.01% | 2790 |
|
|
2018
Q2 | – | Sell |
-6,939
| Closed | -$226K | – | 3610 |
|
|
2018
Q1 | $226K | Buy |
+6,939
| New | +$226K | ﹤0.01% | 3249 |
|
|
2013
Q4 | – | Sell |
-1,529
| Closed | -$144K | – | 4167 |
|
|
2013
Q3 | $144K | Buy |
+1,529
| New | +$144K | ﹤0.01% | 3620 |
|